effect of Withania somnifera root extract in generalized anxiety disorder
Phase 3
- Conditions
- generalized anxiety disorder.Generalized anxiety disorder
- Registration Number
- IRCT20180615040105N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
diagnosed as GAD patients according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
they had to be under the treatment of SSRI drugs with adequate dose and duration
Exclusion Criteria
pregnancy and lactation
comorbidity with other acute psychological disorders
drug abuse and physical disorders which cause anxiety
every accident such as death or immigration
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anxiety score in Hamilton Test. Timepoint: At the onset of the study (before the intervention) and weeks 2, 6. Method of measurement: Anxiety Evaluation by Hamilton Test.
- Secondary Outcome Measures
Name Time Method Quality life score. Timepoint: the onset of the study, second and sixth week. Method of measurement: Score based on Hamilton test.